Yes. Purchasing 5 or more vials earns one free 5mg vial of your choice. Orders of 10+ vials unlock wholesale pricing tiers. For institutional purchasing or high-volume orders, contact us directly for custom quotes.
Author: Vial & Error Labs Research Team
How fast do orders ship?
Most orders ship within 1–2 business days. Domestic orders ship free via USPS Priority Mail with full tracking. All orders are packaged in insulated, discreet packaging designed for transit protection of lyophilized powders.
What payment methods do you accept?
We accept Visa, Mastercard, American Express, Zelle, ACH bank transfer, and Tether (USDT). All card transactions are processed through a secure, PCI-compliant payment processor.
Do you include a Certificate of Analysis (COA) with every order?
Yes — every single order. The COA is lot-specific, sourced directly from the manufacturer, and corresponds to the exact lot shipped to you. We also maintain a publicly accessible COA Library on our website where you can download COAs by SKU, compound name, or lot number.
What purity standard do your compounds meet?
All compounds are verified at ≥98% purity via reverse-phase HPLC with mass spectrometry confirmation. Every order ships with a lot-specific Certificate of Analysis (COA) documenting the exact purity, identity, and testing methodology for that production lot.
GHK-Cu vs BPC-157: Extracellular Matrix vs Tissue Repair Pathways
Two Peptides, Two Systems
GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex, CAS 300801-03-0) and BPC-157 (CAS 1628202-19-6) are both studied in contexts related to tissue repair and regeneration. However, they target fundamentally different biological systems, and treating them as interchangeable reflects a misunderstanding of their mechanisms.
GHK-Cu: Extracellular Matrix Remodeling
GHK-Cu is a tripeptide-copper complex that occurs naturally in human plasma, saliva, and urine. Its primary documented mechanism involves modulation of extracellular matrix (ECM) components. Published research has shown GHK-Cu influences collagen synthesis and organization, glycosaminoglycan production, decorin expression, and matrix metalloproteinase (MMP) activity.
The copper ion is not incidental — it is integral to the biological activity. Copper is a cofactor for lysyl oxidase, an enzyme critical for collagen and elastin cross-linking. The GHK peptide serves as a delivery mechanism for bioavailable copper to tissues, while also possessing independent signaling properties.
This ECM focus makes GHK-Cu particularly relevant to dermal research, wound remodeling studies, and any model where the structural protein matrix is the primary variable of interest.
BPC-157: Multi-Pathway Tissue Repair
BPC-157 operates through a broader set of signaling pathways, including nitric oxide system modulation, growth factor upregulation (VEGF, FGF, HGF), and the FAK-paxillin cell adhesion pathway. Rather than targeting a single system like the ECM, BPC-157 appears to influence multiple upstream signaling cascades that collectively support tissue repair.
This multi-pathway profile gives BPC-157 a wider range of studied applications — from gastrointestinal models to musculoskeletal injury to neuroprotection — but also makes its mechanism harder to isolate in controlled experiments.
Choosing Between Them
The choice between GHK-Cu and BPC-157 should be driven by the research question. If the model focuses on ECM composition, collagen remodeling, or dermal biology, GHK-Cu is the more targeted tool. If the model involves broader tissue repair mechanisms, inflammatory modulation, or GI biology, BPC-157 has a more relevant literature base.
They are not competing products — they are different tools for different questions. Using the wrong one does not create a safety issue in a research context, but it may create a specificity issue that confounds interpretation.
Availability
Vial & Error Labs carries both GHK-Cu (50 mg) and BPC-157 (5 mg) as individual compounds. Both ship with lot-specific COA and GHS-compliant SDS. For research use only.
MOTS-c: The Mitochondrial-Derived Peptide Reshaping Metabolic Research
What Is MOTS-c?
MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded by the mitochondrial genome. First described by Dr. Changhan Lee and colleagues at the University of Southern California in 2015, MOTS-c represents a class of signaling molecules called mitochondrial-derived peptides (MDPs) — peptides encoded within the mitochondrial DNA that function as retrograde signaling molecules, communicating from mitochondria back to the nucleus and other cellular compartments.
This discovery was significant because it challenged the traditional view of mitochondria as purely energy-producing organelles. The identification of MOTS-c and other MDPs demonstrated that mitochondria actively participate in cellular signaling and metabolic regulation through peptide-mediated communication.
Mechanism of Action
AMPK Pathway Activation
The primary documented mechanism of MOTS-c involves activation of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. Published research has shown that MOTS-c activates AMPK by modulating the folate-methionine cycle, which indirectly affects the cellular AMP:ATP ratio. This is distinct from direct AMPK activators like AICAR, which mimic AMP allosterically.
Nuclear Translocation
A particularly notable finding is that MOTS-c has been observed to translocate to the nucleus under metabolic stress conditions. Once in the nucleus, it interacts with transcription factors involved in antioxidant response and metabolic gene regulation. This nuclear translocation has been documented in both cell culture and mouse models, representing a novel signaling paradigm for a mitochondrial-encoded peptide.
Research Applications
Metabolic Signaling Models
The most active area of MOTS-c research involves metabolic regulation. In mouse models, MOTS-c administration has been associated with improved glucose homeostasis, increased insulin sensitivity, and prevention of diet-induced obesity. These effects appear mediated through the AMPK pathway and downstream metabolic gene regulation.
Exercise Biology
MOTS-c has been described as an “exercise mimetic” in research contexts — meaning it activates some of the same metabolic pathways that physical exercise engages. Published studies have shown that circulating MOTS-c levels increase in response to exercise in humans, and that exogenous MOTS-c administration in sedentary mice produces some metabolic adaptations similar to those seen with exercise training.
Aging Research
Because mitochondrial function declines with age, and because endogenous MOTS-c levels appear to decrease in older organisms, the peptide has attracted interest in aging research. Studies in aged mice have shown that MOTS-c treatment improved physical capacity and metabolic parameters. However, this research is in early stages and no conclusions about human aging should be drawn from these animal models.
Current Limitations
MOTS-c research is newer than most peptide fields — the initial discovery paper was published in 2015. While the mechanistic work is compelling, the total volume of published research is smaller than longer-established peptides like BPC-157 or Thymosin Beta-4. Replication across independent laboratories is ongoing.
Additionally, the pharmacokinetics of exogenous MOTS-c in vivo are not fully characterized. Questions remain about bioavailability, half-life, and optimal dosing parameters in research models.
Specifications
Form: Lyophilized powder. Purity: ≥98% (HPLC). Storage: -20°C. Available strength: 10 mg.
MOTS-c from Vial & Error Labs ships with lot-specific COA and SDS documentation. For research use only.
Single Compounds vs Compounded Blends: When Combinatorial Research Makes Sense
The Case for Single Compounds
Single-compound formulations remain the default for most research applications, and for good reason. When you are investigating the effects of a specific molecule on a specific pathway, introducing a second active compound creates confounding variables. If you observe an effect, you cannot attribute it to either compound individually without additional controls.
For mechanism-of-action studies, dose-response characterization, and any research where attribution matters, single compounds are the appropriate choice. This is basic research methodology, not a product recommendation.
When Blends Make Sense
Compounded blends become relevant when the research question itself involves combinatorial effects. If you have already characterized the individual compounds and want to investigate synergistic, additive, or antagonistic interactions between them, a pre-compounded blend offers practical advantages.
Pre-compounded blends ensure consistent ratios between components across preparations, reduce reconstitution steps and potential for preparation error, and simplify inventory management for multi-compound protocols. These are practical advantages, not scientific ones. The research justification for using a blend should come from the experimental design, not from convenience.
Available Blends and Their Rationale
BPC-157 + TB-500
This combination pairs two compounds studied in tissue repair through complementary mechanisms — BPC-157’s growth factor modulation with TB-500’s actin-based cell migration effects. The mechanistic rationale for combinatorial investigation is well-supported by published literature on each compound individually.
CJC-1295 + Ipamorelin
This blend combines a growth hormone releasing hormone (GHRH) analog (CJC-1295) with a ghrelin receptor agonist (Ipamorelin). The two compounds act on different receptors in the growth hormone axis, making their combined study relevant for researchers investigating GH signaling through dual-pathway activation.
AOD-9604 + L-Carnitine
This combination pairs a fragment of human growth hormone studied for its lipolytic properties (AOD-9604) with L-Carnitine, a well-characterized molecule involved in fatty acid transport into mitochondria. The blend targets fat metabolism research through two distinct mechanisms.
Quality Considerations for Blends
When evaluating compounded blends, researchers should verify that both (or all) components are individually tested for purity before compounding, that the COA reflects the blended product and not just one component, and that the SDS accounts for all active ingredients. At Vial & Error Labs, blends are compounded from individually HPLC-verified components, and documentation covers the complete formulation.
For research use only. Not for human or veterinary consumption.
TB-500: Actin Dynamics, Cell Migration, and Preclinical Research Models
What is TB-500?
TB-500 is a synthetic peptide fragment corresponding to the active region of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid protein involved in cell motility, differentiation, and survival. CAS number: 77591-33-4. It is supplied as a lyophilized powder for in vitro and preclinical research.
Thymosin Beta-4 was first isolated from the thymus gland in the 1960s and has since been identified in virtually all mammalian cell types. The synthetic fragment TB-500 replicates the actin-binding domain of the full protein, which is central to its biological activity in research models.
Mechanism of Action
Actin Sequestration and Polymerization
The primary documented mechanism of TB-500 involves its interaction with the actin cytoskeleton. TB-500 binds to monomeric G-actin, preventing premature polymerization into F-actin filaments. This sequestration creates a pool of available actin monomers that can be rapidly deployed for cytoskeletal reorganization — a process essential for cell migration, wound closure, and tissue remodeling.
Cell Migration Promotion
In both in vitro scratch assays and in vivo wound models, TB-500 has been observed to promote directional cell migration. The mechanism appears related to its effects on actin dynamics: by maintaining a readily available pool of G-actin, cells at wound edges can rapidly extend lamellipodia and migrate into the wound space.
Anti-Inflammatory Observations
Several published studies have reported anti-inflammatory effects associated with TB-500 administration in preclinical models. In rodent cardiac injury models, TB-500 treatment was associated with reduced inflammatory cell infiltration and decreased expression of pro-inflammatory cytokines relative to controls. The mechanism underlying these observations has not been fully elucidated.
Research Applications
Wound Healing and Dermal Repair
The most established research application for TB-500 involves wound healing models. Multiple studies have demonstrated accelerated wound closure in rodent models, with increased angiogenesis (new blood vessel formation) at wound sites. These effects have been attributed to both the actin-related migration enhancement and upregulation of vascular endothelial growth factor.
Cardiac Injury Models
Published work in mouse models of myocardial infarction has shown that TB-500 administration post-injury was associated with reduced scar size and improved cardiac function metrics compared to untreated controls. These studies have generated significant interest in Tβ4 biology, though translation to human cardiac research remains in early stages.
Corneal and Ocular Research
TB-500 has been studied in corneal wound healing models, where its effects on epithelial cell migration are particularly relevant. This research has progressed further toward clinical investigation than most other applications, with the full-length Tβ4 protein having entered clinical trials for ophthalmic indications under the name RGN-259.
Limitations and Considerations
As with most peptide research, the TB-500 literature is predominantly preclinical. Rodent and cell culture models make up the vast majority of published data. The translation gap between these models and any human application remains significant.
Researchers should also note that TB-500 (the synthetic fragment) and full-length Thymosin Beta-4 are not identical in all contexts. While they share the actin-binding domain, the full protein contains additional functional regions that may contribute to biological effects observed in some studies.
Specifications
CAS Number: 77591-33-4. Form: Lyophilized powder. Purity: ≥98% (HPLC). Storage: -20°C. Available strength: 10 mg.
All TB-500 from Vial & Error Labs includes a lot-specific COA and GHS-compliant SDS. For research use only.
How to Read a Certificate of Analysis — And What to Look For
What Is a Certificate of Analysis?
A Certificate of Analysis (COA) is an analytical document issued by the manufacturer or an independent testing laboratory that reports the results of quality testing performed on a specific production lot of a compound. It serves as the primary quality assurance document for research reagents and is the closest thing to a “receipt of quality” that exists in the supply chain.
A COA is not a marketing document. It is not a certificate of “goodness” or a general quality claim. It documents specific, measurable test results for a specific batch. Understanding this distinction is the first step in reading one correctly.
Key Sections of a COA
Compound Identification
This section should include the compound name, CAS number, molecular formula, molecular weight, and lot/batch number. The lot number is critical — it ties the test results to the specific batch you received. If the lot number on your vial does not match the lot number on the COA, the document does not apply to your product.
Purity (HPLC)
The most important result on most peptide COAs is the HPLC purity value. This represents the percentage of the total material that is the target compound, as measured by high-performance liquid chromatography. A result of ≥98% means that at least 98% of the detected material is the compound of interest, with ≤2% being other species (synthesis impurities, degradation products, or related substances).
Look for the testing method description: reverse-phase HPLC is standard for peptides. The COA should specify the column type, mobile phase, and detection wavelength — though not all manufacturers include this level of detail.
Identity Confirmation
A purity number alone does not confirm identity — it only tells you that the material is pure, not that it is what it claims to be. Identity confirmation typically comes from mass spectrometry (MS), which verifies the molecular weight matches the expected value. Look for an MS result showing the observed mass matches the theoretical mass within acceptable tolerance.
Appearance and Physical Properties
The COA may describe the physical appearance (e.g., “white to off-white lyophilized powder”), solubility, and pH. These are less quantitative than HPLC and MS but provide baseline expectations for what you should see when you open the vial.
Red Flags on a COA
Missing lot number or batch number (makes the document unverifiable). No HPLC result or a purity result stated as a range without a specific measured value. No mass spectrometry confirmation of identity. Generic or template-style COAs that do not appear to reflect actual testing. COAs dated significantly before or after the labeled production date. Results that exactly match the specification with no variance (e.g., “Purity: 99.0%” every time — real analytical testing produces variable results).
What a Good COA Looks Like
A trustworthy COA includes a specific lot number matching your product, a measured HPLC purity value (not a range), mass spectrometry confirmation, a specific test date, identification of the testing laboratory or manufacturer, and method details or references. Every compound from Vial & Error Labs ships with a lot-specific COA from the manufacturer. Our COA Library provides digital access to these documents by SKU or lot number. If you have questions about a specific COA, contact us. For research use only.
